At1g63080 Antibody

What is At1g63080 and what cellular components does its antibody target?

At1g63080 is a gene locus in Arabidopsis thaliana that is associated with plasma membrane protein function. Antibodies targeting this protein are typically used to study plasma membrane proteins in plant cells. The antibody recognizes specific epitopes of the At1g63080 protein product, which is associated with membrane transport functions. When conducting immunological studies, researchers should note that anti-H+ATPase plasma membrane antibodies may also recognize related ATPases in Arabidopsis thaliana including ATPase 1, 2, 3, 4, 6, 7, 8, 9, and 11, due to sequence homology .

What are the primary applications for At1g63080 antibodies in plant research?

At1g63080 antibodies are valuable tools for several experimental applications in plant research:

• Western blotting (WB): Used at dilutions of 1:1000-1:10,000 to detect the protein in total cell lysates or membrane fractions .

• Immunofluorescence (IF): Employed at dilutions of 1:600-1:1000 to visualize protein localization within cells .

• Immunolocalization (IL): Used at 1:100 dilution to determine subcellular distribution patterns .

• Membrane protein dynamics studies: Particularly effective for monitoring changes in membrane protein composition in response to environmental stimuli .

These applications enable researchers to study membrane protein expression, localization, and dynamics in various plant tissues and under different experimental conditions.

How should At1g63080 antibodies be stored and handled to maintain reactivity?

For optimal performance and longevity of At1g63080 antibodies:

• Storage: Store lyophilized antibody at -20°C. Once reconstituted, continue storing at -20°C in small aliquots to prevent repeated freeze-thaw cycles .

• Reconstitution: Add 50 μl of sterile water to lyophilized antibody preparation .

• Pre-use preparation: Briefly spin tubes before opening to collect material that may adhere to cap or tube walls .

• Critical note: Do not store this antibody at 4°C as this may compromise its reactivity and specificity .

• Aliquoting: After reconstitution, divide into small working aliquots to minimize freeze-thaw cycles that can degrade antibody performance.

Proper handling is crucial for maintaining antibody specificity and sensitivity across experiments.

What protocol modifications are needed for optimal At1g63080 detection in Western blotting?

Optimized Western blot protocol for At1g63080 antibody:

• Sample preparation: Extract total protein using Protein Extraction Buffer (PEB) with a tissue-to-buffer ratio of 1:3-1:5 .

• Protein denaturation: Heat samples at 70°C for 10 minutes to properly denature the protein .

• Gel selection: Use 4-12% gradient gels for optimal separation of membrane proteins .

• Protein loading: Load 20 μg of total protein for whole cell lysates; 2.5 μg is sufficient for enriched plasma membrane fractions .

• Transfer conditions: Transfer to PVDF membrane for 1 hour (recommended over nitrocellulose for membrane proteins) .

• Blocking: Block in TBS-T (20 mM Tris, 137 mM sodium chloride, pH 7.6 with 0.1% Tween-20) for 1 hour at room temperature .

• Primary antibody: Dilute to 1:5,000 and incubate for 1 hour at room temperature with gentle agitation .

• Washing: Rinse briefly twice, wash once for 15 minutes, followed by three 5-minute washes .

• Secondary antibody: Use anti-rabbit IgG HRP-conjugated at 1:20,000 dilution for 1 hour at room temperature .

• Detection: Develop with chemiluminescence reagent for 5 minutes; optimal exposure time is approximately 2 minutes .

This methodology has been validated for detecting plasma membrane H+ATPases across multiple plant species including Arabidopsis thaliana, Hordeum vulgare, Zea mays, and Nicotiana tabacum .

How can immunolocalization protocols be optimized for At1g63080 in different plant tissues?

For successful immunolocalization of At1g63080 in plant tissues:

• Fixation: Fix tissue in para-formaldehyde for 30 minutes to preserve protein localization while maintaining antibody epitope accessibility .

• Tissue preparation: Perform tissue cleaning procedures before immunolocalization to reduce background and improve signal specificity .

• Antibody dilution: Use primary antibody at 1:300 dilution for optimal signal-to-noise ratio in plant tissues .

• Secondary antibody: Use fluorophore-conjugated secondary antibodies (e.g., anti-rabbit IgG with Alexa 555) for visualization .

• Counterstaining: Consider DAPI co-staining to visualize nuclei for better contextual localization .

• Confocal settings: Use appropriate excitation/emission parameters for the selected fluorophores to minimize bleed-through.

• Controls: Always include negative controls (secondary antibody only) and positive controls (known expressing tissue).

This approach has been validated in Arabidopsis root tissues, particularly in the elongation zone, and can be adapted to other plant tissues with appropriate modifications .

What quantification methods are most appropriate for analyzing At1g63080 expression changes?

For reliable quantification of At1g63080 expression changes:

• Western blot densitometry: Use software like Quantity One to measure band intensity relative to control samples .

• Normalization strategy: Normalize against constitutively expressed membrane proteins or total protein loading (visualized by Ponceau S staining).

• Technical replicates: Perform at least three independent experiments to ensure statistical validity .

• Statistical analysis: Apply appropriate statistical tests (e.g., ANOVA with post-hoc tests) to determine significance of observed changes.

• Relative quantification: Express results relative to control samples defined as 1.0 for easier interpretation across experiments .

This quantification approach has been successfully applied in studies examining plasma membrane H+ATPase expression in response to environmental stimuli, as demonstrated in published research on Kandelia obovata seedlings under salt stress and various NO donor treatments .

How can researchers distinguish between different ATPase isoforms when using At1g63080 antibodies?

Distinguishing between ATPase isoforms requires specialized approaches:

• Isoform-specific peptides: Design blocking peptides corresponding to unique regions of specific isoforms to determine antibody cross-reactivity.

• Knockout validation: Use knockout or knockdown lines of specific ATPase isoforms to confirm antibody specificity.

• Immunoprecipitation-Mass Spectrometry: Perform IP-MS to identify which isoforms are being recognized in specific tissues or conditions.

• Sequential probing: Strip and reprobe membranes with isoform-specific antibodies when available.

• Recombinant protein standards: Include purified recombinant proteins of different isoforms as standards on Western blots.

These approaches can help researchers determine whether observed signals represent At1g63080 specifically or include contributions from homologous ATPases like At2g18960 (ATPase 1), At4g30190 (ATPase 2), or others mentioned in the antibody specifications .

What are the critical factors affecting subcellular fractionation quality for At1g63080 detection?

Successful detection of At1g63080 in subcellular fractions depends on these critical factors:

• Membrane isolation buffer composition: Include protease inhibitors and appropriate detergents to maintain protein integrity while facilitating membrane solubilization.

• Centrifugation parameters: Use differential centrifugation with carefully optimized speeds and durations to separate plasma membrane from other cellular compartments.

• Purity verification: Confirm fraction purity using established markers: H+-ATPase for plasma membrane, HDEL proteins for ER, and appropriate markers for other compartments .

• Temperature control: Maintain samples at 4°C throughout the fractionation process to minimize protein degradation.

• Detergent selection: Choose detergents that efficiently solubilize membrane proteins without denaturing the target protein.

Research has shown that appropriate fractionation techniques can reveal important insights about protein translocation between cellular compartments, as demonstrated in studies examining auxin-induced redistribution of proteins between plasma membrane, nucleus, and cytoplasm .

What strategies can address non-specific binding when using At1g63080 antibodies?

To minimize non-specific binding in immunological applications:

• Blocking optimization: Test different blocking agents (BSA, non-fat milk, commercial blockers) to identify optimal conditions for your specific tissue.

• Antibody titration: Perform detailed titration experiments to determine the minimum effective antibody concentration that provides specific signal with minimal background.

• Pre-adsorption: Consider pre-adsorbing antibodies with plant tissue lysates from species known to lack reactivity (e.g., Allium sp., Aspergillus niger, as these have been confirmed non-reactive with this antibody) .

• Wash buffer optimization: Adjust detergent concentrations and salt concentrations in wash buffers to reduce non-specific interactions while maintaining specific binding.

• Signal enhancement strategies: Use signal amplification methods that maintain specificity, such as tyramide signal amplification for immunohistochemistry.

These approaches can significantly improve signal-to-noise ratio, particularly in challenging tissues or when working with low-abundance targets.

How do environmental stressors affect At1g63080 protein expression and distribution?

Research findings on environmental stress responses:

These findings indicate that At1g63080 and related plasma membrane proteins respond dynamically to environmental cues, with both expression levels and subcellular distribution being regulated. This suggests important roles in stress adaptation mechanisms in plants .

What controls should be included when evaluating At1g63080 antibody specificity?

A comprehensive validation approach for At1g63080 antibody specificity should include:

• Genetic controls: Test antibody reactivity in knockout/knockdown lines where At1g63080 expression is reduced or eliminated.

• Tissue-specific controls: Compare reactivity in tissues with known differential expression of At1g63080.

• Cross-species reactivity verification: Test in species with known sequence homology to confirm expected patterns of cross-reactivity or non-reactivity .

• Competitive binding assays: Perform pre-incubation with the immunizing peptide to confirm specificity of the observed signal.

• Secondary antibody-only controls: Include samples treated only with secondary antibody to identify potential non-specific binding.

• Non-reactive species confirmation: Verify absence of signal in species listed as non-reactive (e.g., Allium sp., Aspergillus niger, Citrus limon, and others listed in the specifications) .

This multi-faceted approach provides strong evidence for antibody specificity and helps distinguish true signals from artifacts.

How can researchers integrate At1g63080 antibody data with other experimental approaches?

Integrating antibody-based data with complementary approaches enhances research rigor:

• Transcriptional analysis: Correlate protein expression data from Western blots with transcript levels from RT-qPCR or RNA-seq.

• Functional assays: Combine immunodetection with enzymatic activity assays (e.g., ATPase activity measurements) to correlate protein levels with functional outcomes.

• Protein-protein interaction studies: Use co-immunoprecipitation followed by mass spectrometry to identify interaction partners.

• Live cell imaging: Complement immunolocalization data with fluorescently tagged fusion proteins to analyze dynamics in living cells.

• Structure-function studies: Use antibody epitope mapping combined with mutagenesis to correlate specific protein domains with functional roles.

This integrated approach has been successfully demonstrated in studies examining auxin-induced protein redistribution, where antibody-based detection of plasma membrane markers complemented analysis of fluorescently tagged proteins to reveal complex trafficking mechanisms .

How should protocols be adjusted when using At1g63080 antibodies across different plant species?

Cross-species application requires careful optimization:

• Sequence homology analysis: Before experimental design, analyze sequence homology between At1g63080 and potential homologs in the target species.

• Dilution optimization: Test a range of antibody dilutions in new species, starting with those recommended for Arabidopsis but exploring both higher and lower concentrations.

• Known reactive species: Prioritize work with confirmed reactive species like Arabidopsis thaliana, Hordeum vulgare, Zea mays, and Nicotiana tabacum .

• Non-reactive species: Be aware that this antibody has been confirmed non-reactive in several species including Allium sp., Aspergillus niger, and others listed in the specifications .

• Sample preparation modifications: Adjust extraction buffers and protocols based on the tissue type and species-specific characteristics (e.g., presence of secondary metabolites).

When adapting protocols to new species, pilot experiments with appropriate controls are essential to validate antibody performance before proceeding with larger studies.

What are the critical differences when analyzing At1g63080 in mutant versus wild-type plant lines?

Key considerations for comparative studies between mutant and wild-type lines:

• Growth conditions standardization: Ensure identical growth conditions to prevent environmentally-induced variations in protein expression.

• Developmental stage matching: Compare tissues at equivalent developmental stages rather than simply matching chronological age.

• Loading control selection: Choose loading controls unaffected by the mutation; plasma membrane H+-ATPase can serve as a reliable marker for membrane protein normalization .

• Phenotypic correlation: Document and correlate phenotypic differences with observed changes in protein expression or localization.

• Quantitative analysis: Apply rigorous statistical analysis to quantitative data, particularly for subtle differences in expression levels.

These approaches help distinguish primary effects of the mutation from secondary consequences or unrelated variations.

What emerging techniques are enhancing At1g63080 antibody-based research?

Recent methodological advances expanding the utility of At1g63080 antibodies include:

• Super-resolution microscopy: Techniques like STORM and PALM now allow visualization of membrane protein distribution at nanometer resolution, revealing previously undetectable organization patterns.

• Proximity labeling approaches: Methods like BioID and APEX can be combined with antibody detection to identify proteins in close proximity to At1g63080 in native contexts.

• Single-cell Western blotting: Emerging technologies enable protein detection at the single-cell level, revealing cell-to-cell variability in expression.

• Multiplexed imaging: New approaches allow simultaneous detection of multiple proteins in the same sample, facilitating colocalization studies.

• Quantitative immunoprecipitation: Combining IP with quantitative proteomics allows assessment of dynamic interaction networks under different conditions.

These technological advances are opening new avenues for understanding the dynamics and functions of plasma membrane proteins in plant biology.

How can researchers address contradictory findings in At1g63080 expression studies?

When confronted with contradictory results:

• Protocol standardization: Compare experimental protocols in detail, as seemingly minor differences in sample preparation, antibody dilutions, or detection methods can significantly impact results.

• Environmental conditions: Evaluate whether differences in plant growth conditions, light cycles, temperature, or stress exposure might explain discrepancies.

• Developmental timing: Consider whether samples were collected at different developmental stages, as expression patterns often change throughout development.

• Antibody lot variation: Test whether different antibody lots were used, as lot-to-lot variation can affect specificity and sensitivity.

• Quantification methods: Examine differences in data normalization and quantification approaches that might lead to divergent interpretations of similar underlying data.

By systematically addressing these potential sources of variation, researchers can reconcile apparently contradictory findings and develop a more comprehensive understanding of At1g63080 biology.